The relevance of this research direction was reinforced by the fact that PD-L1 is expressed by the tumor cells in patient biopsies in both TNBC and luminal A subtypes, with a more prevalent expression in the first than in the latter [7,8,9]. The gene discussed is CD274; the disease is neoplasm.